Humanized antibody or fragments thereof, which bind to the epidermal growth factor receptor (egfr) in an aberrant expression or truncated egfr? 2-7; host cell; pharmaceutical composition comprising it; and its use to treat cancer.
Номер патента: CL2011002003A1
Опубликовано: 25-05-2012
Автор(ы): Christoph Renner, Lloyd Old, Terrance Grant Jonhs
Принадлежит: Ludwig Inst For Cancer Res Ltd
Опубликовано: 25-05-2012
Автор(ы): Christoph Renner, Lloyd Old, Terrance Grant Jonhs
Принадлежит: Ludwig Inst For Cancer Res Ltd
Реферат: Anticuerpo aislado que es capaz de unirse al receptor del factor de crecimiento epidérmico (egfr); ácido nucleico que lo codifica; célula huésped; método de producción; composición farmacéutica que lo comprende; su uso para tratar cáncer; kit de diagnóstico; y método de detección. Isolated antibody that is capable of binding to the epidermal growth factor receptor (egfr); nucleic acid encoding it; host cell; Method of production; pharmaceutical composition comprising it; its use to treat cancer; diagnostic kit; and detection method.
Anti-epidermal growth factor receptor (EGFR) antibodies
Номер патента: US10584171B2. Автор: Wei-Dong Jiang,pei-hua Lin. Владелец: Henlix Biotech Co Ltd. Дата публикации: 2020-03-10.